Delivery Order SPE2DB25D3002-SPE2DB25FLQPF
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,753.03, is for the delivery of the prescription medication Addyi (flibanserin) 100 mg tablets. It is a firm fixed-price contract with a completion date of May 2, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,635.69, is for the supply of Addyi 100 mg tablets. The contract is a firm fixed-price delivery order, with a period of performance through February 2025. The award is not associated with any set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,991.05, is for the delivery of 4,568,060,997 units of the prescription medication Addyi (flibanserin) 100 mg tablets. The contract has a firm fixed price and an ultimate completion date of April 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,854.50, is for the delivery of Addyi 100mg tablets over a period ending on May 19, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,336.67, is for the delivery of 4,567,967,784 units of the prescription medication Addyi 100 mg tablets. The contract has an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside for any specific type of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,880.43, is a delivery order for Addyi 100 mg tablets under the DLA's Troop Support Medical program. The contract has an ultimate completion date of January 23, 2024 and is a firm-fixed price arrangement. The contract award was not designated with a set-aside requirement, indicating open...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Addyi 100 mg tablets. The $1,544.40 firm fixed-price contract has an ultimate completion date of April 12, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,792.12, is for the delivery of Addyi 100 mg tablets. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,476.07, is for the delivery of ADDYI 100 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 14, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $3,436.06, is for the delivery of ADDYI 100 MG TABLET UU 30S, a pharmaceutical product. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as...